Employees Retirement System of Texas Sells 115,100 Shares of SPDR S&P Biotech ETF $XBI

Employees Retirement System of Texas reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.5% during the third quarter, HoldingsChannel reports. The fund owned 738,272 shares of the exchange traded fund’s stock after selling 115,100 shares during the quarter. Employees Retirement System of Texas’ holdings in SPDR S&P Biotech ETF were worth $73,975,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its position in SPDR S&P Biotech ETF by 27.3% during the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after purchasing an additional 2,900,633 shares during the period. Bessemer Group Inc. raised its position in shares of SPDR S&P Biotech ETF by 9.3% in the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock valued at $163,624,000 after purchasing an additional 138,322 shares during the period. Ameriprise Financial Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after buying an additional 481,408 shares in the last quarter. Meitav Investment House Ltd. lifted its stake in shares of SPDR S&P Biotech ETF by 70.3% during the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock valued at $68,156,000 after buying an additional 281,602 shares in the last quarter. Finally, Greenhouse Funds LLLP boosted its holdings in SPDR S&P Biotech ETF by 16.6% in the 3rd quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock worth $67,733,000 after buying an additional 96,308 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $122.62 on Friday. The stock has a market capitalization of $8.19 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The company’s fifty day simple moving average is $125.47 and its two-hundred day simple moving average is $114.78. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $132.09.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.